Conmed (CNMD) Tops Q2 EPS by 1c; Raises Outlook
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $51.07 -0.6%
Financial Fact:
Income from operations: 13.85M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Income from operations: 13.85M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Conmed (NASDAQ: CNMD) reported Q2 EPS of $0.46, $0.01 better than the analyst estimate of $0.45. Revenue for the quarter came in at $212.8 million versus the consensus estimate of $207.12 million.
GUIDANCE:
Conmed sees FY2018 EPS of $2.15-$2.20, versus the consensus of $2.17.
For earnings history and earnings-related data on Conmed (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
